Haha - I've got just a dwindling specky holding. That's the problem with little specky positions, you don't notice the share price dwindling away within the context of the rest of the portfolio. Oh well, that's what speckies are for - to the moon or bust!
Looking at the chart there is no support anywhere in sight. This could hit the covid low of $0.275. I guess the headline figure of Q2 CY21 revenue being below Q2 CY20 would be a turnoff for some shareholders given this is a pre-profit.
I imagine these sort of medical innovations take considerable time to gain acceptance and then generate sales. COVID-19, etc ,etc....
EDIT to add, none of my biotechs have done well lately. It's just that stage in the market cycle, speckie biotechs did well in the COVID crash recovery but the market churned over into "value" stocks a while ago.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)